As March Madness moves into the Final Four, some degenerate gamblers, sports aficionados or both are still looking to capitalize on their bracket pools. Saturday…
March 23, 2024
The Next Blockbuster? FDA Approvals in 2024
Drug development is an arduous, costly and time-consuming process for the teams involved behind the scenes, and the patients anxiously awaiting breakthroughs in different disease…
March 20, 2024
Stock Picks That Could Make Barry Manilow Think You Raid His Wardrobe – A Breakfast Club Edition
In today’s world of AI and technology, there are some memories of the past that still hold a true nostalgia for the more simplistic times…
This week, Madrigal Therapeutics (Nasdaq: MDGL) won FDA approval for Rezdiffra™, the first and only drug to be approved for metabolic dysfunction-associated steatohepatitis (MASH). The…
Ibogaine, a potent psychedelic derived from the root of a Central African shrub, is making headlines for its potential to revolutionize the treatment of opioid…
February 28, 2024
Bone Cancer: Rare Disease Taking a Share of the Biotech Spotlight
Bone cancer is rare, making up just one percent of all cancer cases. Despite advances in treatment for other cancers, the standard of care for…
February 20, 2024
AI Companies Shaping Tomorrow: A Jetsons-Worthy Portfolio Selection
Artificial Intelligence or “AI” seems to be the new, hot two letter word on everybody’s lips. If you’re a CEO mentioning AI on an earnings…
The FDA has approved the first new frontline treatment for metastatic pancreatic cancer in more than a decade. This week, global biopharmaceutical company, Ipsen, announced…
February 03, 2024
Are We Investing Enough in Vaccine Development?
Vaccination is one of the top 10 most significant public health achievements of the 20th century and remains the most effective preventive measure against infectious…
January 30, 2024
GRAMMY Centric Stock Picks That May Help You “Like the Life You Live and Go from Negative to Positive…”
As the new year kicks off, award shows are rolling out those red carpets left and right. And who doesn’t like attending a good viewing…
After a record 104 initial public offerings (IPO) in 2021, biotech ground almost to a halt with just 21 IPOs recorded in 2022, and 20…
Dow +1.05%, S&P 500 +1.23%, Nasdaq +1.70%, Russell 2000 +1.08% Healthcare equities finished the week flat, with Healthcare up +0.06% versus the S&P 500 which…